Home
Mail
News
Sport
Finance
Celebrity
Style
Weather
Mobile
Messenger
Movies
More
Yahoo
Mail
Finance Home
News
Market Data
Crypto
Bank of England
Money Matters
Property
Top Stocks
Work & Management
Industry News
Brexit
My Portfolio
My Screeners
Watchlists
Videos
UK markets closed
FTSE 100
7,901.80
+81.64
(+1.04%)
FTSE 250
20,593.46
-21.23
(-0.10%)
AIM
889.79
+1.03
(+0.12%)
GBP/EUR
1.1163
-0.0042
(-0.37%)
GBP/USD
1.2056
-0.0173
(-1.41%)
BTC-GBP
19,403.04
-38.55
(-0.20%)
Centessa Pharmaceuticals plc (CNTA)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
3.6200
-0.2500
(-6.46%)
At close: 04:00PM EST
3.6200
0.00
(0.00%)
After hours:
04:00PM EST
Summary
Chart
Conversations
Statistics
Historical data
Profile
Financials
Analysis
Options
Holders
Sustainability
Show
:
Income statement
Balance sheet
Cash flow
Annual
Quarterly
Income statement
All numbers in thousands
Breakdown
ttm
31/12/2020
31/12/2019
Total revenue
-
0
0
Operating expenses
Research development
-
9,301
4,263
Selling general and administrative
-
1,139
790
Total operating expenses
-
10,440
5,053
Operating income or loss
-
-10,440
-5,053
Interest expense
-
378
118
Total other income/expenses net
-
155
105
Income before tax
-
-10,663
-5,061
Income from continuing operations
-
-10,663
-5,061
Net income
-
-10,663
-5,061
Net income available to common shareholders
-
-10,663
-5,061
Basic EPS
-
-0.15
-0.07
Diluted EPS
-
-0.15
-0.07
Basic average shares
-
70,891
70,891
Diluted average shares
-
70,891
70,891
EBITDA
-
-10,285
-4,937
© 2023 Yahoo. All rights reserved.
Data disclaimer
Help
Suggestions
Terms
Privacy
Privacy Dashboard
About our ads